glp-1 drugs review The New Frontiers | Exploring the multifaceted

1 Introduction Obstructive sleep apnea syndrome (OSAS) is a chronic sleep-related breathing disorder characterized by recurrent upper airway collapse during sleep, leading to intermittent hypoxemia, sleep architecture disruption, and impaired daytime functioning (1, 2)

The weekly dosing is more forgiving, the bioavailability ensures consistent medication levels, and the weight loss results are backed by extensive clinical research

Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management

Current Opinion in Rheumatology

doi:10.1016/j.ajo.2024.04.010 20

One article found an increased incidence of aspiration pneumonia among GLP-1 users compared to non-users reporting a hazard ratio of 1.33 (95%CI 1.021.74, p = 0.036) (Australian Diabetes Society, National Association of Clinical Obesity Services, Gastroenterological Society of Australia, and Australian and New Zealand College of Anaesthetists n.d.)